Anti-venom potential of butanolic extract of Eclipta prostrata against Malayan pit viper venom.
暂无分享,去创建一个
P. Pithayanukul | Pimolpan Pithayanukul | Sasitorn Laovachirasuwan | Rapepol Bavovada | Narumol Pakmanee | Rutt Suttisri | R. Suttisri | R. Bavovada | N. Pakmanee | Sasitorn Laovachirasuwan
[1] H. Reid,et al. Clinical effects of bites by Malayan viper (Ancistrodon rhodostoma). , 1963, Lancet.
[2] C. Ownby,et al. Ability of wedelolactone, heparin, and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA2 myotoxins. , 1999, Toxicon : official journal of the International Society on Toxinology.
[3] R. Theakston,et al. Development of simple standard assay procedures for the characterization of snake venom. , 1983, Bulletin of the World Health Organization.
[4] G. Suarez-Kurtz,et al. Neutralization of lethal and myotoxic activities of South American rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (Asteraceae). , 1989, Toxicon : official journal of the International Society on Toxinology.
[5] V. Núñez,et al. Snakebites and ethnobotany in the northwest region of Colombia. Part III: neutralization of the haemorrhagic effect of Bothrops atrox venom. , 2000, Journal of ethnopharmacology.
[6] H. Wagner,et al. Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea. , 1986, Planta medica.
[7] H. Ikezawa,et al. Studies on the quantitative method for determination of hemorrhagic activity of Habu snake venom. , 1960, Japanese journal of medical science & biology.
[8] G. Suarez-Kurtz,et al. Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (Asteraceae) extracts and constituents. , 1994, Toxicon : official journal of the International Society on Toxinology.
[9] J. Fox,et al. Hemorrhagic metalloproteinases from snake venoms. , 1994, Pharmacology & therapeutics.
[10] M. Kunitz,et al. CRYSTALLINE SOYBEAN TRYPSIN INHIBITOR : II. GENERAL PROPERTIES. , 1947 .
[11] F. Markland. Snake venoms and the hemostatic system. , 1998, Toxicon : official journal of the International Society on Toxinology.
[12] J. Gutiérrez,et al. An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica. , 1988, Toxicon : official journal of the International Society on Toxinology.
[13] W. B. Mors,et al. Plant natural products active against snake bite--the molecular approach. , 2000, Phytochemistry.
[14] H. Wagner,et al. In-Vitro-5-Lipoxygenasehemmung durch Eclipta alba Extrakte und das Coumestan-Derivat Wedelolacton , 1986 .
[15] J. Gené,et al. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. , 1985, Toxicon : official journal of the International Society on Toxinology.
[16] N. Tan,et al. Enzymatic activities of Calloselasma rhodostoma (Malayan pit viper) venom. , 1986, Toxicon : official journal of the International Society on Toxinology.
[17] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .
[18] W. Bell,et al. Snake venoms. Discussion , 1997 .
[19] V. Núñez,et al. Snakebites and ethnobotany in the northwest region of Colombia: Part II: neutralization of lethal and enzymatic effects of Bothrops atrox venom. , 2000, Journal of ethnopharmacology.
[20] D. Warrell,et al. A national hospital-based survey of snakes responsible for bites in Thailand. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.